Popular on s4story
- AdvisorVault Releases New Explainer Video on their 17a-4 Managed 365 Service - 126
- RNHA FL Unveils Bold New Leadership Ahead of 2026 Elections - 119
- Mullins McLeod Surges Into SC Governor's Race with $1.4 Million Raised in First Quarter; Most from His Own Commitment, Not Political Pockets - 117
- Root Canal Specialist In Frederick Maryland Joins Pearlfection Dentistry
- Dr. Frederic Scheer to Speak at Big Sky AI Forum in Bozeman, Montana
- Award-Winning YA Novel Allie's Adventure on the Wonder to Shine on a Times Square Billboard
- Hiclean Tools Releases HCX2100 Electric Pressure Washer
- Some Music for Donald's Bad Day
- Final Countdown: The OpenSSL Conference 2025 Begins in One Week
- Unique Retelling of the Christmas Story
Similar on s4story
- OddsTrader Reveals Early Favorites and Best Bets to Win March Madness 2026
- Bookmakers Review Releases 2028 Democratic Nominee Betting Odds: Newsom Leads Early Field
- Genuine Smiles Unveils New User-Friendly Website
- Nusign Global Launch Event Concludes Successfully, Embarking on a New International Chapter
- Lift Solutions Holdings Announces Exclusive Distributorship for Advanced Camera and Sensor Products from Automate Matrix
- Political Division and Safety Concerns Drive Record Number of Americans to Seek "Golden Visas," La Vida Survey Finds
- Engaged at Any Age: 73-Year-Old Client Finds True Love Through Elite Asian Matchmaker
- Launch of Professional Private Autopsy Services to Support Families, Professionals, and Researchers
- He Started a New Career at 77; Maybe Not His Last
- $73.6 Million in Order Backlog Poised for Explosive Growth in 2026; Streamlined Share Structure: Cycurion, Inc. (N A S D A Q: CYCU) $CYCU
PAOG Previews Next Acquisition Anticipated In Conjunction With CRO Partnership And CTAP Application
S For Story/10432597
SANDUSKY, Ohio, July 31, 2020 /PRNewswire/ -- PAO Group, Inc. (USOTC: PAOG) today previewed its next acquisition after just this week closing the acquisition of a cannabis biopharmaceutical asset to treat Chronic Obstructive Pulmonary Disease (COPD) and a cannabis cultivation operation developing a proprietary cannabis cultivar.
The COPD treatment, RespRx, is derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT."
PAOG anticipates soon entering into a Contract Research Organization (CRO) agreement in conjunction with advancing an Investigational New Drug Application (IND) to ultimately achieve Food and Drug Administration (FDA) approval for RespRx as a COPD treatment.
Based on positive results from an informal trial of RexpRX with 25 COVID-19 patients, PAOG also plans to make Coronavirus Treatment Acceleration Program (CTAP) application after entering into a CRO agreement.
More on S For Story
PAOG has a working agreement to close the acquisition of the underlying extraction patent in conjunction with executing the CRO agreement. The CRO agreement and corresponding acquisition are anticipated to close by the end of August.
CEO James C. DiPrima discusses the PAOG CRO, IND and CTAP developments in his interview on MoneyTV with Donald Baillargeon released today.
MoneyTV with Donald Baillargeon is the internationally syndicated television program all about money and what makes it happen, featuring informative interviews with company CEOs and executives, providing insights into their operations and outlooks for their futures. MoneyTV is seen in over 200 million TV households in more than 75 countries.
The MoneyTV Interview is available at www.moneytv.net and will be syndicated across multiple channels and platforms.
More on S For Story
Forward-Looking Statements: Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.
CONTACT INFORMATION
Contact Us:
Jim DiPrima
888-272-6472
[email protected]
SOURCE PAO Group, Inc.
The COPD treatment, RespRx, is derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT."
PAOG anticipates soon entering into a Contract Research Organization (CRO) agreement in conjunction with advancing an Investigational New Drug Application (IND) to ultimately achieve Food and Drug Administration (FDA) approval for RespRx as a COPD treatment.
Based on positive results from an informal trial of RexpRX with 25 COVID-19 patients, PAOG also plans to make Coronavirus Treatment Acceleration Program (CTAP) application after entering into a CRO agreement.
More on S For Story
- Announcing Halloween eBook Giveaway Promoting Health, Creativity, & Calm for Silver Seniors
- Heritage at South Brunswick's Townhome Models Coming Soon!
- Get More Done Today! Discover How to Own the Day and Control Your Life In The Perfect Day Formula by Author Craig Ballantyne
- PatientNow Acquires Recura, the AI Growth Engine Powering Practice Growth
- Everything You Know About Discipline Is Wrong
PAOG has a working agreement to close the acquisition of the underlying extraction patent in conjunction with executing the CRO agreement. The CRO agreement and corresponding acquisition are anticipated to close by the end of August.
CEO James C. DiPrima discusses the PAOG CRO, IND and CTAP developments in his interview on MoneyTV with Donald Baillargeon released today.
MoneyTV with Donald Baillargeon is the internationally syndicated television program all about money and what makes it happen, featuring informative interviews with company CEOs and executives, providing insights into their operations and outlooks for their futures. MoneyTV is seen in over 200 million TV households in more than 75 countries.
The MoneyTV Interview is available at www.moneytv.net and will be syndicated across multiple channels and platforms.
More on S For Story
- Working Too Much and Not Getting the Results You Want?
- Boston Industrial Solutions Unveils New and Improved Natron® UV Screen Printing Ink
- Genuine Smiles Unveils New User-Friendly Website
- Nusign Global Launch Event Concludes Successfully, Embarking on a New International Chapter
- Lift Solutions Holdings Announces Exclusive Distributorship for Advanced Camera and Sensor Products from Automate Matrix
Forward-Looking Statements: Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.
CONTACT INFORMATION
Contact Us:
Jim DiPrima
888-272-6472
[email protected]
SOURCE PAO Group, Inc.
Filed Under: Business
0 Comments
Latest on S For Story
- Osric Langevin Unveils "Quantitative Trend" Framework for Multi-Asset Analysis in Q4 2025
- Experience Days Named Among the UK's Top Christmas Gifts
- New Book Empowers Readers to Embrace Life Changes
- New Bilingual Stories from On the Land of Games Now Available on Kindle
- New Free Educational Bingo Cards Make Learning English Fun for First Graders
- Wzzph Provides Stablecoin Trading Solutions for Latin American Traders Amid Digital Currency Policy Adjustments
- NaturismRE Calls for Recognition of AI as Sentient Kin in Global Bill of Rights
- Guillermo X. Márquez Debuts True Crime and Supernatural Comedy Fiction Books
- PDS Plumbing & Air Honors Veterans with "Free Tune-Up & A Turkey" Giveaway
- AgeImmune Announces the Launch of ImmuneG.I. — A Doctor-Formulated Herbal Supplement Supporting Gut and Digestive Wellness
- "Blushbottoms: The Belonging Bear" Launches A Heartfelt Story of Love, Hope, and Finding Home
- Precision Adult Care Unveils Essential Guidelines for Choosing a Senior Home Care Company
- Postmortem Pathology Delivers Expert Private Autopsy Services with Compassion and Precision
- Colorado Families Turn to Private Autopsies for Peace of Mind
- $5.4 Million Growth Acceleration, Fleet Expansion and $1.485 Million Strategic Financing: Multi Ways Holdings (N Y S E: MWG) $MWG
- Delta Capital Group Expands Business Funding Terms Up to 24 Months
- City of Hawthorne Honors Multiple Award-Winning Architect and Author Mario Cartaya for Hispanic Heritage Month
- Mary Lee Painter Releases New Holiday Romcom Holiday on the Rocks
- "War Year Champions" Reveals the Challenges of NFL Football during World War II
- Hip-HopVibe.com Launches HHV Media Network in Partnership with The Publisher Desk